Advertisement
Advertisement
U.S. Markets open in 1 hr 23 mins
Advertisement
Advertisement
Advertisement
Advertisement

ShockWave Medical, Inc. (SWAV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
264.27+0.21 (+0.08%)
At close: 01:00PM EST
255.01 -9.26 (-3.50%)
Pre-Market: 08:00AM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/28/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.07
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3320.54
52 Week Low 3113.36
50-Day Moving Average 3270.43
200-Day Moving Average 3218.42

Share Statistics

Avg Vol (3 month) 3486.48k
Avg Vol (10 day) 3426.12k
Shares Outstanding 535.3M
Implied Shares Outstanding 6N/A
Float 835.55M
% Held by Insiders 11.11%
% Held by Institutions 196.13%
Shares Short (Oct 13, 2022) 41.67M
Short Ratio (Oct 13, 2022) 43.93
Short % of Float (Oct 13, 2022) 44.71%
Short % of Shares Outstanding (Oct 13, 2022) 44.65%
Shares Short (prior month Sep 14, 2022) 41.76M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 15.11%
Operating Margin (ttm)16.98%

Management Effectiveness

Return on Assets (ttm)11.13%
Return on Equity (ttm)21.41%

Income Statement

Revenue (ttm)363.72M
Revenue Per Share (ttm)10.25
Quarterly Revenue Growth (yoy)116.00%
Gross Profit (ttm)195.71M
EBITDA 65.79M
Net Income Avi to Common (ttm)54.97M
Diluted EPS (ttm)-1.99
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)224.91M
Total Cash Per Share (mrq)6.26
Total Debt (mrq)47.28M
Total Debt/Equity (mrq)15.50
Current Ratio (mrq)5.32
Book Value Per Share (mrq)6.51

Cash Flow Statement

Operating Cash Flow (ttm)60.96M
Levered Free Cash Flow (ttm)27.3M
Advertisement
Advertisement